Cowen & Co. Downgrades Northrop Grumman to Market Perform, Announces $478 Price Target
Cowen & Co. analyst Cai Rumohr downgrades Northrop Grumman (NYSE:NOC) from Outperform to Market Perform and announces $478 price target.
Piper Sandler Downgrades Origin Bancorp to Neutral, Lowers Price Target to $41
Piper Sandler analyst Brad Milsaps downgrades Origin Bancorp (NASDAQ:OBNK) from Overweight to Neutral and lowers the price target from $46 to $41.
Goldman Sachs Downgrades Steel Dynamics to Neutral, Raises Price Target to $118
Goldman Sachs analyst Emily Chieng downgrades Steel Dynamics (NASDAQ:STLD) from Buy to Neutral and raises the price target from $114 to $118.
Why This Pfizer Analyst Is No Longer Bullish On The COVID Stock
Pfizer Inc. (NYSE: PFE) could see headwinds in 2023 due to declining COVID-19 cases, according to a UBS analyst.
BTIG Downgrades Magenta Therapeutics to Neutral
BTIG analyst Yun Zhong downgrades Magenta Therapeutics (NASDAQ:MGTA) from Buy to Neutral.
Keefe, Bruyette & Woods Downgrades Popular to Market Perform, Lowers Price Target to $74
Keefe, Bruyette & Woods analyst Kelly Motta downgrades Popular (NASDAQ:BPOP) from Outperform to Market Perform and lowers the price target from $85 to $74.
B of A Securities Downgrades NextEra Energy to Neutral, Lowers Price Target to $80
B of A Securities analyst Julien Dumoulin-Smith downgrades NextEra Energy (NYSE:NEE) from Buy to Neutral and lowers the price target from $94 to $80.
Wedbush Downgrades Carter’s to Neutral, Announces $78 Price Target
Wedbush analyst Tom Nikic downgrades Carter's (NYSE:CRI) from Outperform to Neutral and announces $78 price target.
Deutsche Bank Downgrades Nasdaq to Hold, Lowers Price Target to $60
Deutsche Bank analyst Brian Bedell downgrades Nasdaq (NASDAQ:NDAQ) from Buy to Hold and lowers the price target from $72 to $60.
JP Morgan Downgrades EVgo to Neutral, Lowers Price Target to $6
JP Morgan analyst Bill Peterson downgrades EVgo (NASDAQ:EVGO) from Overweight to Neutral and lowers the price target from $10 to $6.